Cobblestone Capital Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,556
| Closed | -$245K | – | 309 |
|
|
2025
Q2 | $245K | Hold |
3,556
| – | – | 0.01% | 271 |
|
|
2025
Q1 | $247K | Hold |
3,556
| – | – | 0.01% | 264 |
|
|
2024
Q4 | $306K | Sell |
3,556
-5
| -0.1% | -$541 | 0.02% | 238 |
|
|
2024
Q3 | $424K | Buy |
3,561
+5
| +0.1% | +$667 | 0.02% | 207 |
|
|
2024
Q2 | $508K | Hold |
3,556
| – | – | 0.03% | 177 |
|
|
2024
Q1 | $457K | Hold |
3,556
| – | – | 0.03% | 182 |
|
|
2023
Q4 | $368K | Sell |
3,556
-574
| -14% | -$56.8K | 0.02% | 203 |
|
|
2023
Q3 | $376K | Hold |
4,130
| – | – | 0.03% | 182 |
|
|
2023
Q2 | $334K | Hold |
4,130
| – | – | 0.02% | 202 |
|
|
2023
Q1 | $329K | Hold |
4,130
| – | – | 0.02% | 205 |
|
|
2022
Q4 | $279K | Hold |
4,130
| – | – | 0.02% | 222 |
|
|
2022
Q3 | $206K | Hold |
4,130
| – | – | 0.02% | 236 |
|
|
2022
Q2 | $230K | Hold |
4,130
| – | – | 0.02% | 226 |
|
|
2022
Q1 | $229K | Sell |
4,130
-792
| -16% | -$40.6K | 0.02% | 240 |
|
|
2021
Q4 | $276K | Buy |
4,922
+216
| +5% | +$11.7K | 0.02% | 229 |
|
|
2021
Q3 | $226K | Buy |
+4,706
| New | +$228K | 0.02% | 239 |
|
|
2018
Q1 | – | Sell |
-7,964
| Closed | -$214K | – | 246 |
|
|
2017
Q4 | $214K | Sell |
7,964
-1,820
| -19% | -$46.3K | 0.02% | 229 |
|
|
2017
Q3 | $236K | Sell |
9,784
-4,120
| -30% | -$93.1K | 0.03% | 181 |
|
|
2017
Q2 | $298K | Sell |
13,904
-175,864
| -93% | -$3.55M | 0.04% | 161 |
|
|
2017
Q1 | $3.25M | Sell |
189,768
-1,220
| -0.6% | -$21.2K | 0.43% | 52 |
|
|
2016
Q4 | $3.42M | Sell |
190,988
-2,170
| -1% | -$39.3K | 0.47% | 49 |
|
|
2016
Q3 | $4.02M | Sell |
193,158
-1,226
| -0.6% | -$30.4K | 0.57% | 47 |
|
|
2016
Q2 | $5.23M | Sell |
194,384
-3,156
| -2% | -$86.5K | 0.75% | 43 |
|
|
2016
Q1 | $5.35M | Sell |
197,540
-386
| -0.2% | -$10.3K | 0.78% | 36 |
|
|
2015
Q4 | $5.75M | Sell |
197,926
-1,160
| -0.6% | -$32.1K | 0.86% | 35 |
|
|
2015
Q3 | $5.4M | Sell |
199,086
-5,030
| -2% | -$142K | 0.86% | 31 |
|
|
2015
Q2 | $5.59M | Buy |
204,116
+784
| +0.4% | +$22K | 0.84% | 34 |
|
|
2015
Q1 | $5.43M | Sell |
203,332
-596
| -0.3% | -$13.7K | 0.84% | 38 |
|
|
2014
Q4 | $4.32M | Sell |
203,928
-420
| -0.2% | -$9.38K | 0.77% | 43 |
|
|
2014
Q3 | $4.87M | Sell |
204,348
-1,634
| -0.8% | -$37.6K | 0.9% | 35 |
|
|
2014
Q2 | $4.76M | Sell |
205,982
-107,408
| -34% | -$2.37M | 0.89% | 38 |
|
|
2014
Q1 | $7.15M | Buy |
313,390
+6,420
| +2% | +$137K | 1.38% | 21 |
|
|
2013
Q4 | $5.67M | Buy |
306,970
+8,390
| +3% | +$146K | 1.08% | 36 |
|
|
2013
Q3 | $5.05M | Buy |
298,580
+13,060
| +5% | +$220K | 1.03% | 37 |
|
|
2013
Q2 | $4.42M | Buy |
+285,520
| New | +$4.75M | 0.97% | 41 |
|
Other funds holding NVO
F
Cobblestone Capital Advisors's NVO Position: Q3 2025 in Review
Cobblestone Capital Advisors sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,556 shares — an estimated $245K sold.
Cobblestone Capital Advisors first reported a position in NVO in Q2 2013 and held it in 35 quarters. The position peaked at $7.15M in Q1 2014. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.
- Cobblestone Capital Advisors reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
- Cobblestone Capital Advisors sold 3,556 Novo Nordisk shares in Q3 2025, an estimated $245K.
- Cobblestone Capital Advisors first reported a position in Novo Nordisk in Q2 2013 and held it in 35 quarters.
- Cobblestone Capital Advisors's Novo Nordisk position peaked at $7.15M in Q1 2014.
- 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.
Based on Cobblestone Capital Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.